Chimeric-antigen receptor engineered human T lymphocytes from induced pluripotent stem cells for cancer therapy.

被引：0
|
作者：
Themeli, Maria [1 ]
Sadelain, Michel [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF IMMUNOLOGY | 2014年 / 192卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
VAC11P1003
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights
    Obstfeld, Amrom E.
    Frey, Noelle V.
    Mansfield, Keith
    Lacey, Simon F.
    June, Carl H.
    Porter, David L.
    Melenhorst, Jan J.
    Wasik, Mariusz A.
    BLOOD, 2017, 130 (23) : 2569 - 2572
  • [42] Chimeric Antigen Receptor-Engineered T Cell Therapy in Lymphoma
    Strati, Paolo
    Neelapu, Sattva S.
    CURRENT ONCOLOGY REPORTS, 2019, 21 (05)
  • [43] Advances in chimeric antigen receptor T cells therapy in the treatment of breast cancer
    He, Qingjie
    Hu, Haibo
    Yang, Fan
    Song, Dong
    Zhang, Xiaoling
    Dai, Xiangpeng
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [44] Computational model of chimeric antigen receptor-engineered T cells
    Rohrs, Jennifer
    Wang, Pin
    Finley, Stacey D.
    CANCER RESEARCH, 2015, 75 (22)
  • [45] Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
    Thangaraj, Jaya Lakshmi
    Kaufman, Dan S.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2025, (216):
  • [46] Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
    Klaihmon, Phatchanat
    Luanpitpong, Sudjit
    Kang, Xing
    Issaragrisil, Surapol
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [47] Graded potency of chimeric antigen receptor (CAR)-engineered T cells for cancer immunotherapy.
    Sadelain, Michel
    Condomines, Maud
    Zhao, Zeguo
    Brentiens, Renier J.
    Riviera, Isabelle
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] A bispecific chimeric-antigen receptor T-cell factory for triple-negative breast cancer
    Kuiper, Emily G.
    Chan, Leo L.
    Chang, Matthew R.
    Zhu, Quan K.
    Marasco, Wayne A.
    CANCER RESEARCH, 2018, 78 (13)
  • [49] Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
    Phatchanat Klaihmon
    Sudjit Luanpitpong
    Xing Kang
    Surapol Issaragrisil
    Cancer Cell International, 23
  • [50] Chimeric antigen receptor T cells for cancer immunotherapy
    Curran, Kevin J.
    Silverman, Lewis B.
    Kobos, Rachel
    Kernan, Nancy A.
    Margossian, Steven P.
    Park, Jae H.
    Sauter, Craig S.
    Szenes, Victoria
    Wang, Xiuyan
    O'Reilly, Richard J.
    Sadelain, Michel
    Riviere, Isabelle
    Brentjens, Reiner J.
    CANCER RESEARCH, 2016, 76
12345